Show simple item record

dc.contributor.advisor Johnston, Jeffrey N en_US
dc.contributor.author Yoder, Ryan Adam en_US
dc.date.accessioned 2010-06-04T14:50:04Z
dc.date.available 2027-02-04T15:50:04Z
dc.date.available 2011-10-06T15:13:43Z
dc.date.issued 2010-06-04T14:50:04Z
dc.date.submitted 2008 en_US
dc.identifier.uri http://hdl.handle.net/2022/8095
dc.description Thesis (PhD) - Indiana University, Chemistry, 2008 en_US
dc.description.abstract The proton (H+) is arguably Nature's most common Lewis acid and is utilized by many enzymes to carry out asymmetric transformations. These "natural" Brønsted acid catalysts have served as an inspiration to synthetic organic chemists for the development of both regioselective and stereoselective bond forming reactions. Inspired by Nature's elegance and motivated by the demand for inexpensive, robust and environmentally friendly catalysts, a Brønsted acid catalyst called the chiral proton was developed. This catalyst relies upon polar ionic hydrogen bonding for substrate activation and as a primary control element for enantioselection. The catalyst system was based on a coordination complex between a proton and a chiral, C2-symmetric BisAMidine ligand (BAM). This complex has demonstrated the ability to both activate and control the absolute and relative stereochemistry in the addition of silyl nitronates to Boc-protected imines. It was further demonstrated that nitroalkanes could be used in place of silyl nitronates (aza-Henry reaction), eliminating the need for preformation of the nucleophile. In the latter reaction, the amount of catalyst could be reduced to as low as 1 mol% without loss of enantioselectivity, attesting to the BAM ligand's ability to sequester protons from bulk solvent. The products of this reaction provide access to enantioenriched 1,2-diamines. Furthermore, this catalyst system has been successfully applied to the enantioselective synthesis of both syn and anti α,β-diamino acids. The chiral BAM-protic acid complexes were further applied to the stereoselective intramolecular hetero-Diels-Alder reactions of azadienes. These catalysts were found to influence both the endo/exo selectivity, as well as the facial selectivity of the [4+2] cycloadditions. The azadienes used in this study were modeled after the putative Diels-Alder precursors in the biosynthesis of the brevianamide class of natural products. In addition, a novel Diels-Alder reaction was hypothesized as an alternative route to the synthesis of oseltamivir phosphate (Tamiflu). A model system was chosen to examine the effectiveness of this route. The chiral proton catalyst was shown to catalyze this model reaction to produce the desired exo Diels-Alder adduct. en_US
dc.language.iso EN en_US
dc.publisher [Bloomington, Ind.] : Indiana University en_US
dc.rights This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) License
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/
dc.subject diels-alder en_US
dc.subject chiral proton en_US
dc.subject aza-henry en_US
dc.subject organocatalysis en_US
dc.subject tamiflu en_US
dc.subject brevianamide en_US
dc.subject.classification Chemistry, Organic en_US
dc.title Chiral Proton Catalysis: Design and Development of Enantioselective Aza-Henry and Diels-Alder Reactions en_US
dc.type Doctoral Dissertation en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) License This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) License

Search IUScholarWorks


Advanced Search

Browse

My Account

Statistics